HKD 6.21
(0.16%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 134.73 Million CNY | 33.09% |
2022 | 132.78 Million CNY | -8.78% |
2021 | 145.56 Million CNY | -25.13% |
2020 | 194.4 Million CNY | -1.99% |
2019 | 198.35 Million CNY | -7.29% |
2018 | 213.95 Million CNY | 14.68% |
2017 | 186.56 Million CNY | 42.0% |
2016 | 130.77 Million CNY | 22.22% |
2015 | 102.98 Million CNY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 33.64 Million CNY | 0.0% |
2023 Q4 | 76.28 Million CNY | 0.0% |
2023 FY | - CNY | 33.09% |
2023 Q2 | 58.45 Million CNY | 0.0% |
2022 FY | - CNY | -8.78% |
2022 Q4 | 73.84 Million CNY | 0.0% |
2022 Q2 | 58.94 Million CNY | 0.0% |
2021 Q4 | 74.07 Million CNY | 0.0% |
2021 Q2 | 71.49 Million CNY | 0.0% |
2021 FY | - CNY | -25.13% |
2020 Q4 | 108.9 Million CNY | 0.0% |
2020 FY | - CNY | -1.99% |
2020 Q2 | 85.5 Million CNY | 0.0% |
2019 FY | - CNY | -7.29% |
2019 Q4 | 117.32 Million CNY | 0.0% |
2019 Q2 | 81.02 Million CNY | 0.0% |
2018 Q2 | 98.3 Million CNY | 0.0% |
2018 FY | - CNY | 14.68% |
2018 Q4 | 109.38 Million CNY | 0.0% |
2017 Q2 | 101.4 Million CNY | 0.0% |
2017 FY | - CNY | 42.0% |
2017 Q4 | 80.76 Million CNY | 0.0% |
2016 Q1 | 32.69 Million CNY | 0.0% |
2016 FY | - CNY | 22.22% |
2016 Q4 | 46.42 Million CNY | 0.0% |
2016 Q2 | 32.69 Million CNY | 0.0% |
2015 Q1 | 25.74 Million CNY | 0.0% |
2015 Q3 | 25.74 Million CNY | 0.0% |
2015 FY | - CNY | 0.0% |
2015 Q4 | 32.69 Million CNY | 26.97% |
2015 Q2 | 25.74 Million CNY | 0.0% |
2014 Q4 | 25.74 Million CNY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Starlite Holdings Limited | 71.42 Million HKD | -88.629% |
Litu Holdings Limited | 1.21 Million HKD | -11016.832% |
Touyun Biotech Group Limited | -228.56 Million HKD | 158.948% |
Champion Alliance International Holdings Limited | 35.89 Million HKD | -275.33% |
Huaxi Holdings Company Limited | -31.47 Million HKD | 528.019% |